EU/1/08/461/001 |
52459 |
Firazyr 30 mg injek?ný roztok v naplnenej injek?nej strieka?ke |
sol inj 1x3 ml/30 mg (striek.skl.napln.) |
SHP-IE-1 |
|
EU/1/09/601/001 |
86926 |
FIRDAPSE 10 mg tablety |
tbl 100(10x10)x10 mg (blis.PVC/PVDC/Al) |
BAN |
28.12.2019 |
EU/1/15/1082/001 |
9811B |
Galafold 123 mg tvrdé kapsuly |
cps dur 14x123 mg (blis. PVC/PCTFE/PVC/Al) |
AIU |
26.05.2021 |
EU/1/14/937/001 |
1191B |
Gazyvaro 1 000 mg infúzny koncentrát |
con inf 1x40 ml (liek inj.skl.) |
HLR-DE |
23.07.2019 |
EU/1/13/896/001 |
0171B |
GRANUPAS 4 g gastrorezistentný granulát |
gra ent 1x4 g (vre.papier/LDPE/Al/LDPE) |
EUC-1 |
07.04.2019 |
EU/1/15/1008/001 |
5172B |
HETLIOZ 20 mg tvrdé kapsuly |
cps dur 30x20 mg (f?.HDPE) |
VND |
03.07.2020 |
EU/1/14/987/001 |
3265B |
Holoclar 79 000 - 316 000 buniek/cm2 transplantát |
tra 1x3,8 cm2 (nádoba- nehrdz.oce?) |
CHS |
19.02.2019 |
EU/1/13/839/005 |
5684B |
Iclusig 15 mg filmom obalené tablety |
tbl flm 30x15 mg (f?.HDPE) |
ICY-NL |
|
EU/1/13/839/002 |
6385A |
Iclusig 15 mg filmom obalené tablety |
tbl flm 180x15 mg (f?.HDPE) |
ICY-NL |
|
EU/1/13/839/001 |
6384A |
Iclusig 15 mg filmom obalené tablety |
tbl flm 60x15 mg (f?.HDPE) |
ICY-NL |
|
EU/1/13/839/006 |
7509B |
Iclusig 30 mg filmom obalené tablety |
tbl flm 30x30 mg (f?.HDPE) |
ICY-NL |
|
EU/1/13/839/004 |
6387A |
Iclusig 45 mg filmom obalené tablety |
tbl flm 90x45 mg (f?.HDPE) |
ICY-NL |
|
EU/1/13/839/003 |
6386A |
Iclusig 45 mg filmom obalené tablety |
tbl flm 30x45 mg (f?.HDPE) |
ICY-NL |
|
EU/1/16/1095/003 |
9502B |
IDELVION 1000 IU prášok a rozpúš?adlo na injek?ný roztok |
plv iol 1x1000 IU+2,5 ml solv. (liek.inj.skl.) |
CSL |
11.05.2021 |
EU/1/16/1095/004 |
9503B |
IDELVION 2000 IU prášok a rozpúš?adlo na injek?ný roztok |
plv iol 1x2000 IU+2,5 ml solv. (liek.inj.skl.) |
CSL |
11.05.2021 |
EU/1/16/1095/001 |
9500B |
IDELVION 250 IU prášok a rozpúš?adlo na injek?ný roztok |
plv iol 1x250 IU+2,5 ml solv. (liek.inj.skl.) |
CSL |
11.05.2021 |
EU/1/16/1095/002 |
9501B |
IDELVION 500 IU prášok a rozpúš?adlo na injek?ný roztok |
plv iol 1x500 IU+2,5 ml solv. (liek.inj.skl.) |
CSL |
11.05.2021 |
EU/1/14/945/003 |
8451C |
IMBRUVICA 140 mg filmom obalené tablety |
tbl flm 10x140 mg (blis.PVC/PCTFE/Al) |
JNS |
21.10.2019 |
EU/1/14/945/002 |
2190B |
IMBRUVICA 140 mg tvrdé kapsuly |
cps dur 120x140 mg (f?.HDPE) |
JNS |
21.10.2019 |
EU/1/14/945/001 |
2189B |
IMBRUVICA 140 mg tvrdé kapsuly |
cps dur 90x140 mg (f?.HDPE) |
JNS |
21.10.2019 |
EU/1/14/945/004 |
8452C |
IMBRUVICA 280 mg filmom obalené tablety |
tbl flm 10x280 mg (blis.PVC/PCTFE/Al) |
JNS |
21.10.2019 |
EU/1/14/945/005 |
8453C |
IMBRUVICA 420 mg filmom obalené tablety |
tbl flm 30x420 mg (blis.PVC/PCTFE/Al) |
JNS |
21.10.2019 |
EU/1/14/945/006 |
8454C |
IMBRUVICA 560 mg filmom obalené tablety |
tbl flm 30x560 mg (blis.PVC/PCTFE/Al) |
JNS |
21.10.2019 |
EU/1/13/850/001 |
6541A |
Imnovid 1 mg tvrdé kapsuly |
cps dur 21x1 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/002 |
6542A |
Imnovid 2 mg tvrdé kapsuly |
cps dur 21x2 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/003 |
6798A |
Imnovid 3 mg tvrdé kapsuly |
cps dur 21x3 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/004 |
6799A |
Imnovid 4 mg tvrdé kapsuly |
cps dur 21x4 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/06/378/005 |
37870 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 100x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/004 |
37869 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 60x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/003 |
37868 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 50x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/002 |
37867 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 30x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/001 |
37866 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 10x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/010 |
37875 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 100x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/009 |
37874 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 60x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/008 |
37873 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 50x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/007 |
37872 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 30x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/006 |
37871 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 10x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/017 |
31927 |
Inovelon 40 mg/ml perorálna suspenzia |
sus por 1x460 ml/18,4 g (f?.PET) |
XEI-DE |
|
EU/1/06/378/016 |
37881 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 200x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/015 |
37880 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 100x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/014 |
37879 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 60x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/013 |
37878 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 50x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/012 |
37877 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 30x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/011 |
37876 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 10x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/17/1254/005 |
6909C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 100x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/004 |
6908C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 90x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/003 |
6907C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 60x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/002 |
6906C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 30x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/17/1254/001 |
6905C |
Jorveza 1 mg orodispergovate?né tablety |
tbl oro 20x1 mg (blis.Al/Al) |
FAK |
08.01.2023 |
EU/1/12/782/002 |
2178A |
Kalydeco 150 mg filmom obalené tablety |
tbl flm 56x150 mg (blis.aclar/Al) |
VET-1 |
25.07.2022 |